Alcami enhances analytical services in Edison, NJ

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Ca-ssis)
(Image: iStock/Ca-ssis)
The latest in a series of investments, Alcami has strengthened its analytical services capabilities at its Edison, New Jersey-based site.

The CDMO offers comprehensive chemistry, environmental, and microbial capabilities at the facilities, in addition to multi-compendial testing and customized analysis.

According to the company, the Edison site is capable of meeting FDA requirements for Antibiotic Analysis both using USP < 81 > and can perform bridging analysis to an alternative method per USP < 1223.1 >. 

Additionally, Alcami has added​ 2,000 cubic feet of stability chamber space across its network, new control systems for all chambers, and a REES environmental monitoring system.

The company is also working to adopt Lean principles at its laboratories, a process which is said will be completed in 2017.

Alcami did not respond to a request for comment.

Related news

Show more

Related products

show more

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Featured Events

View more


View more